Impact of Subsequent Treatment on Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Transformed to Small-Cell Lung Cancer

Lung Cancer: Targets and Therapy · Published 2025-04-01 · DOI 10.2147/lctt.s516527

Authors being retrieved — see the publisher record. https://doi.org/10.2147/lctt.s516527

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2025

Related articles

Transformation of NSCLC to SCLC: Insights into Molecular Alterations, Tumor Origin, and Therapeutic Advancements · Onco · 2026 · Cites or is cited by this article
Prevalence of EGFR Mutations in Vietnamese Patients with Resected Early Stage Non-Small Cell Lung Cancer: EARLY-EGFR Study · Lung Cancer: Targets and Therapy · 2025 · Same journal
Exploratory Identification of Gene Copy Number Cut-Off for NGS-Based MET Amplification Assessment and Clinical Relevance to MET Inhibitor Outcomes in Non-Small-Cell Lung Cancer · Lung Cancer: Targets and Therapy · 2025 · Same journal
HER2-ADC and HER2-TKI Overcomes HER2 Amplification as an Acquired Resistance to Zongertinib – A Case Report · Lung Cancer: Targets and Therapy · 2025 · Same journal
Evaluation of the Effectiveness and Safety Profile of First-Line Immune Checkpoint Inhibitors Combined with Chemotherapy in Pulmonary Sarcomatoid Carcinoma · Lung Cancer: Targets and Therapy · 2025 · Same journal
The Butterfly Flies - Practice Changing Results of PAPILLON, First Line Chemotherapy and Amivantamab for the Treatment of NSCLC Patients with EGFR Exon 20 Insertions · Lung Cancer: Targets and Therapy · 2024 · Same journal
Genomic Profiling of Extensive Stage Small-Cell Lung Cancer Patients Identifies Molecular Factors Associated with Survival · Lung Cancer: Targets and Therapy · 2025 · Same journal
Pulmonary Nodular Lymphoid Hyperplasia: Reviewing a Lung Cancer Mimicker · Lung Cancer: Targets and Therapy · 2025 · Same journal
CodeBreaK 200: Sotorasib (AMG510) Has Broken the KRAS G12C+ NSCLC Enigma Code · Lung Cancer: Targets and Therapy · 2023 · Same journal
Reduced Claudin-3 Expression Is Linked to Unfavorable Tumor Features and Poor Prognosis in Non-Small Cell Lung Cancer · Lung Cancer: Targets and Therapy · 2026 · Same journal